Surrogate Outcomes: An Inevitable Limitation of Hyperbilirubinemia-Driven Randomized Controlled Trials
Neonatology
.
2020;117(6):694-696.
doi: 10.1159/000512021.
Epub 2020 Dec 1.
Authors
Michael Kaplan
1
2
,
Cathy Hammerman
3
4
Affiliations
1
Department of Neonatology, Shaare Zedek Medical Center, Jerusalem, Israel, mkaplan@mail.huji.ac.il.
2
Faculty of Medicine of the Hebrew University, Jerusalem, Israel, mkaplan@mail.huji.ac.il.
3
Department of Neonatology, Shaare Zedek Medical Center, Jerusalem, Israel.
4
Faculty of Medicine of the Hebrew University, Jerusalem, Israel.
PMID:
33260178
DOI:
10.1159/000512021
No abstract available
Publication types
Comment
MeSH terms
Humans
Hyperbilirubinemia*
Infant, Newborn
Randomized Controlled Trials as Topic